Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

Clinical trial NCT00124709 · TERMINATED

Trial details

NCT number: NCT00124709
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2003-10-01
Primary completion: 2008-01-01
Enrollment: 1091

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.